New Noninvasive Colorectal Cancer Test Shows Promise

  • Screening test measures DNA changes in three genes and detects occult blood.
  • Test shows 83 percent sensitivity for precancer with high-grade dysplasia.

ANAHEIM, CA. –  A new noninvasive test for colorectal cancer screening demonstrated high sensitivity for detecting colorectal cancer, in particular precancers that are most likely to develop into cancer, according to data presented at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research, held here Oct. 16-19, 2012.

Read More